Integrating AIEgen-based phototherapy and gas-mediated immunostimulation strategy of cGAS-STING pathway activation into the virus-inspired gas nanoadjuvant illustrates a paradigm for photoimmunotherapy of poorly immunogenic tumor. This evidence concerns the gene CGAS and neoplasm.